Niswander, L. M., Graff, Z. T., Chien, C. D., Chukinas, J. A., Meadows, C. A., Leach, L. C., Loftus, J. P., Kohler, M. E., Tasian, S. K. and Fry, T. J. (2023) “Potent preclinical activity of FLT3-directed chimeric antigen receptor T-cell immunotherapy against <i>FLT3</i>- mutant acute myeloid leukemia and <i>KMT2A</i&gt;-rearranged acute lymphoblastic leukemia”, Haematologica. Pavia, Italy, 108(2), pp. 457-471. doi: 10.3324/haematol.2022.281456.